Skip to main content

Corporate insider profile

Michael A Metzger Insider Trades

Michael A Metzger has reported no open-market purchases on SEC Form 4 and is a net seller of $914,801 across 1 company. The most recent open-market transaction was reported on Jul 8, 2026. Source: SEC Form 4 filings.

Latest reported as Chief Executive Officer of Syndax Pharmaceuticals Inc (SNDX).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$914,801.01
Latest transaction
Jul 8, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 8, 2026Syndax Pharmaceuticals Inc (SNDX)Chief Executive OfficerSale32,375$24.24$784,776
Jun 1, 2026Syndax Pharmaceuticals Inc (SNDX)Chief Executive OfficerSale6,847$18.99$130,025

Common questions

Michael A Metzger insider trading FAQ

Is Michael A Metzger buying or selling stock?
Across all SEC Form 4 open-market filings on record, Michael A Metzger is a net seller of $914,801, with no open-market purchases reported. The latest transaction was reported on Jul 8, 2026.
Which companies does Michael A Metzger report insider trades for?
Michael A Metzger has reported open-market trades in Syndax Pharmaceuticals Inc (SNDX). The latest SEC-reported relationship is Chief Executive Officer of Syndax Pharmaceuticals Inc (SNDX).
Where does Michael A Metzger's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1507220, and refreshes this page daily.